Documents

Use of a new plant extract-based product in acute purulent rhinosinusitis

BEZSHAPOCHNY S.
Director of the Otorhinolaryngology Department
of the Ukrainian Academy of Medicine and
Odontology Rhinologist General of the Ukraine

Therapeutics and Clinical Risk Management.
Special Issue in Spanish. Supplement I 2006.
Therapeutics and clinical risk management 2006 - PDF


ABSTRACT

Acute rhinosinusitis is a very common disease in our country.
Although several causes have been described for this disease, it is considered that obstruction of the drainage orifices from the paranasal sinuses to the nasal passages is the fundamental factor in the development of this type of condition, both by retaining secretions, which foster bacterial growth, and by decreasing oxygen supply, favouring the growth of anaerobic germs.
Although various treatments have been used to improve this disease, there is a percentage of patients who suffer from complications arising from rhinosinusitis. Furthermore, the drugs can also cause adverse effects. The administration of certain plant extracts activates physiological cleansing mechanisms, facilitating natural secretion in the paranasal sinuses and, by this means, clearing the purulent matter accumulated in the sinuses, thereby relieving the symptoms associated with this disease.

We present our experience in the use of a plant extract-based product in 28 patients diagnosed with acute purulent rhinosinusitis.

Use of a new plant extract-based product in acute purulent rhinosinusitis - Full article

Therapeutics and clinical risk management 2006 - Index

Use of a new plant extract-based product in inflammatory diseases - Next abstract

Hartington Pharma owns Nasodren® for sinusitis treatment